Luteolin Treats Obese Rats With Polycystic Ovary Syndrome by Improving Liver Lipid Metabolism and Regulating the Gut Microbiota

Documenti analoghi

• Ginsenosides From Panax ginseng Improves Hepatic Lipid Metabolism Disorders in HFD ‐Fed Rats by Regulating Gut Microbiota and Cholesterol Metabolism Signaling Pathways
  di: Yue Zhu, et al.
  Pubblicazione: (2024)
• Resveratrol Alleviates Inflammation in Polycystic Ovary Syndrome by Inhibiting Absent in Melanoma 2 Expression
  di: Qianjie Zhang, et al.
  Pubblicazione: (2026)
• Chlorogenic Acid Ameliorates Lipid Metabolism Disorders via Gut Microbiota‐Serum Metabolite‐Liver Axis in High‐Fat Diet‐Induced Obesity
  di: Zhineng Wang, et al.
  Pubblicazione: (2026)
• Astragaloside IV Exhibited Antidiabetic Effects by Improving Glucose Metabolism, Repairing Damaged Gut Barrier and Regulating Intestinal Microbiota
  di: Xiaolei Yang, et al.
  Pubblicazione: (2026)
• Gut Microbiota and Bile Acid Metabolism in the Mechanism of Ginsenoside Re Against Nonalcoholic Fatty Liver Disease
  di: Yanfang Zheng, et al.
  Pubblicazione: (2025)